This February 29th, PharPoint acknowledges Rare Disease Day. We are relentless in supporting clients so that they may advance rare disease research and the approval of breakthrough treatments.
Information regarding the novel coronavirus is rapidly evolving as scientists and public-health officials race to uncover important details on the spread and treatment of the virus. Explore PharPoint’s news roundup and learn more about our extensive infectious disease experience.
How do you perform non-eCRF data (ECG, Labs, PK) reconciliation in EDC platforms like Medrio? A PharPoint clinical trial expert answers as part of our #askaclinicaltrialexpert blog series.
For our upcoming study, we know we want to use EDC—but there are so many options. How should we choose an EDC provider? As part of our Ask a Clinical Trial Expert blog series, a PharPoint clinical trial expert answers.
We’re worried that the service providers working on our study are causing it to fall behind. Timelines are being missed due to slow enrollment and data quality is poor. What are our options? A member of the PharPoint leadership team discusses options for study rescues in this Ask a Clinical Trial Expert blog series post.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.